94 related articles for article (PubMed ID: 15335447)
1. On not being the "hostess with the mostest".
Sledge GW
Clin Breast Cancer; 2004 Aug; 5(3):171. PubMed ID: 15335447
[No Abstract] [Full Text] [Related]
2. The challenge of using SNPs in the understanding and treatment of disease.
Schifreen RS; Storts DR; Buller AM
Biotechniques; 2002 Jun; Suppl():14-6, 18, 20-1. PubMed ID: 12083392
[No Abstract] [Full Text] [Related]
3. Influence of single nucleotide polymorphism in IL-27 and IL-33 genes on breast cancer.
Fathi Maroufi N; Gholampour Matin M; Ghanbari N; Khorrami A; Amini Z; Haj Azimian S; Isazadeh A; Taefehshokr S; Taefehshokr N; Baradaran B
Br J Biomed Sci; 2019 Apr; 76(2):89-91. PubMed ID: 30406733
[No Abstract] [Full Text] [Related]
4. SNPs in ultraconserved elements and familial breast cancer risk.
Catucci I; Verderio P; Pizzamiglio S; Manoukian S; Peissel B; Barile M; Tizzoni L; Bernard L; Ravagnani F; Galastri L; Pierotti MA; Radice P; Peterlongo P
Carcinogenesis; 2009 Mar; 30(3):544-5; author reply 546. PubMed ID: 19126653
[No Abstract] [Full Text] [Related]
5. Need for clarification of data in the recent meta-analysis about RAD51 135G>C polymorphism and breast cancer risk.
He XF; Su J; Zhang Y; Ding DP; Wang W; Liu Y
Breast Cancer Res Treat; 2011 Sep; 129(2):649-51; author reply 652-3. PubMed ID: 21537934
[No Abstract] [Full Text] [Related]
6. Tumor necrosis factor-α 308 G/A polymorphism in breast cancer risk.
Ding Z; Jiang F; Ding X; Chen S; Lv G
Breast Cancer Res Treat; 2011 Jul; 128(2):593-4. PubMed ID: 21350819
[No Abstract] [Full Text] [Related]
7. Genetics. DNA test for breast cancer risk draws criticism.
Couzin J
Science; 2008 Oct; 322(5900):357. PubMed ID: 18927361
[No Abstract] [Full Text] [Related]
8. Need for clarification of results in the recent meta-analysis about SULT1A1 codon 213 polymorphism and breast cancer risk.
Lu PH; Wei MX; Li C; Liu X; Chen MB
Breast Cancer Res Treat; 2011 Jan; 125(2):599-600. PubMed ID: 20949371
[No Abstract] [Full Text] [Related]
9. Eligible and not eligible studies in the recent meta-analysis about p53 polymorphism and breast cancer risk.
Sergentanis TN; Economopoulos KP
Breast Cancer Res Treat; 2010 Feb; 120(1):261-2. PubMed ID: 19760041
[No Abstract] [Full Text] [Related]
10. Genomics and pharmacogenomics of breast cancer: current knowledge and trends.
Ayoub N; Lucas C; Kaddoumi A
Asian Pac J Cancer Prev; 2011; 12(5):1127-40. PubMed ID: 21875255
[TBL] [Abstract][Full Text] [Related]
11. [Current status of genome-wide association studies (GWAS) on breast cancer and application values of single nucleotide polymorphisms identified from GWAS].
Huang Y; Song F; Chen K
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Oct; 36(10):1058-61. PubMed ID: 26837343
[No Abstract] [Full Text] [Related]
12. Re: Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium.
Baker SG
J Natl Cancer Inst; 2007 Mar; 99(6):487-8; author reply 488-9. PubMed ID: 17374838
[No Abstract] [Full Text] [Related]
13. Methylenetetrahydrofolate reductase haplotype tag single-nucleotide polymorphisms and risk of breast cancer.
Martin YN; Olson JE; Ingle JN; Vierkant RA; Fredericksen ZS; Pankratz VS; Wu Y; Schaid DJ; Sellers TA; Weinshilboum RM
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2322-4. PubMed ID: 17119067
[No Abstract] [Full Text] [Related]
14. New pharmacogenomic paradigm in breast cancer treatment.
Offit K; Robson ME
J Clin Oncol; 2010 Nov; 28(31):4665-6. PubMed ID: 20876427
[No Abstract] [Full Text] [Related]
15. Is RAD51 135G>C polymorphism really associated with breast cancer in general population? Biased design and results lead to inappropriate conclusion.
Yu KD; Li B; Zhou Y; Shao ZM
Breast Cancer Res Treat; 2011 Jul; 128(1):297-9; author reply 300. PubMed ID: 21331620
[No Abstract] [Full Text] [Related]
16. Re: Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium.
Ambrosone CB; Shields PG; Freudenheim JL; Hong CC
J Natl Cancer Inst; 2007 Mar; 99(6):487; author reply 488-9. PubMed ID: 17374839
[No Abstract] [Full Text] [Related]
17. Common genetic variants for breast cancer: 32 largely refuted candidates and larger prospects.
Ioannidis JP
J Natl Cancer Inst; 2006 Oct; 98(19):1350-3. PubMed ID: 17018776
[No Abstract] [Full Text] [Related]
18. A tiny step closer to personalized risk prediction for breast cancer.
Devilee P; Rookus MA
N Engl J Med; 2010 Mar; 362(11):1043-5. PubMed ID: 20237351
[No Abstract] [Full Text] [Related]
19. Host Factors and Risk of Breast Cancer Recurrence: Genetic, Epigenetic and Biologic Factors and Breast Cancer Outcomes.
Ambrosone CB; Hong CC; Goodwin PJ
Adv Exp Med Biol; 2015; 862():143-53. PubMed ID: 26059934
[TBL] [Abstract][Full Text] [Related]
20. Polygenes, risk prediction, and targeted prevention of breast cancer.
Jernström H
N Engl J Med; 2008 Sep; 359(13):1407. PubMed ID: 18822457
[No Abstract] [Full Text] [Related]
[Next] [New Search]
